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IsoproterenolAbstract The present study was designed to discover the potential cardioprotective function of
earthworm powder (EWP) extracted from Eudrilus eugeniae on isoproterenol (ISO)-induced
myocardial infarction in male Wistar rats. The rats were divided into four groups, with six rats
in each group. Certain rats were pretreated with EWP (200 mg/kg bwt) (Group III), and a myocar-
dial infarction was then induced by subcutaneous injection of ISO (85 mg/kg bwt) (Group II). Oral
pretreatment of 200 mg/kg bwt of EWP for 28 days significantly (p> 0.05) improved the blood
profile levels, including (a) the lipid profile of total cholesterol (TC), free fatty acids (FFA), and
triglycerides (TG); (b) low-density lipoprotein (LDL), very low-density lipoprotein (VLDL),
high-density lipoprotein (HDL), and protein; and (c) A/G ratio, glucose and uric acid levels. The
electrophoretic pattern of elevated lactose dehydrogenase (LDH) levels was recovered by EWP
treatment as evidenced by comparison with ISO-induced rats with cardiac damage. The above
results indicate that EWP (200 mg/kg bwt) provides a cardioprotective effect by attenuating the
blood profile, lipid profile, biochemical levels, and LDH patterns in rats that experienced an
ISO-induced myocardial infarction.
 2016 The Egyptian German Society for Zoology. Production and hosting by Elsevier B.V. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Myocardial infarction (MI) is a condition characterized by an
imbalance between the myocardial oxygen supply and demand
(Mohanty et al., 2004). Accumulating evidence suggests that
reactive oxygen-derived free radicals play a crucial role in the
2 J. Anitha et al.pathogenesis of isoproterenol (ISO)-induced myocardial infarc-
tion (Nirmala and Puvanakrishnan, 1996). The effects of ISO on
the myocardium are mediated through b1 and b2 adrenocep-
tors. Both b1 and b2 adrenoceptors mediate the positive isotro-
pic and chronotropic effects of b adrenoceptor agonists. Thus,
ISO produce relative ischemia or hypoxia due to myocardial
hyperactivity and coronary hypotension (Brodde, 1991). ISO
additionally causes myocardial ischemia due to the excessive
production of free radicals resulting from the oxidative metabo-
lism of catecholamine (Gunjal et al., 2010). Further toxic
dosages of ISO cause characteristic myocardial damage that
subsequently results in heart failure (Liu et al., 2012).
Myocardial proteins, lipids, and DNA play an important
role in cardiovascular diseases by modifying the composition,
structure, and stability of cell membranes. Studies have shown
that high levels of total cholesterol, triglycerides, and low-
density lipoprotein cholesterol and low levels of high-density
lipoprotein cholesterol are risk factors for cardiovascular
diseases. Reactive oxygen species may contribute to the events
associated with atherogenesis and lead to the progression of
atherogenic lesions by promoting the oxidation of
low-density lipoproteins (Upaganlawar and Balaraman, 2012).
Lactate dehydrogenase (LDH) is an enzyme present in a wide
variety of organisms, including plants and animals that exist as
five isoenzymes (LD1, LD2, LD3, LD4, and LD5). The differen-
tial distribution of LDH isoenzymes enables its use in differential
diagnosis, as a marked increase in the proportion of LD1 in the
serum indicates myocardial infarction (Nigam, 2007).
A better understanding of the processes involved in myocar-
dial infarction has stimulated the search for new drugs that
could limit myocardial injury. Recently, earthworms have been
the subject of widespread investigation because they have
unique therapeutic properties, including anti-inflammatory,
anti-oxidative, antitumor, and anti-bacterial effects
(Balamurugan et al., 2007). Earthworm powder (EWP) of
Eudrilus eugeniae is a good source of protein, carbohydrates,
fat, micro and macro minerals, vitamins, and antioxidants
(Anitha and Jayraaj, 2012). The free radical scavenging poten-
tial of EWP helps to reduce the oxidative damage induced by
ISO and to restore both enzymatic and non-enzymatic antiox-
idants in rat models without any adverse side effects (Anitha
and Jayraaj, 2014). Based on these facts, in this study, we inves-
tigated the cardioprotective activity of EWP obtained from E.
eugeniae against ISO-induced myocardial infarction in rats.
Methods and methods
Materials
The living earthworm E. eugeniae was collected from Aarthi
farms, Kondegoundan palayam village, Pollachi Taluk, Coim-
batore District, Tamil Nadu, India. Isoproterenol hydrochlo-
ride, filter papers, solvents and all other chemicals were of
analytical grade and were acquired from Sigma–Aldrich
Chemicals, Mumbai, India. Double distilled water was used
in all the biochemical assays.
Extraction and preparation of earthworm powder
The earthworms were washed with running tap water to
remove any dirt from the body surface. The earthworms werekept in 0.5% NaCl at room temperature for 1–2 h with a few
solution changes until their digestive systems were clean. The
cleaned earthworms were taken out of the solution and minced
with scissors. Fifteen grams of earthworm tissue was homoge-
nized in 40 ml of chloroform–methanol (v/v) solution and left
overnight at 4 C. The following day, 16 ml of distilled water
was added to the homogenate. The solution was mixed and
centrifuged at 2460g for 10 min. Three clearly visible layers
were obtained. The upper water/methanol layer was removed
by pipette and evaporated on a rotary evaporator until the
methanol was vaporized, and an opalescent solution was sub-
sequently obtained at pH7. The solution was then freeze-dried,
and the earthworm powder (EWP) was stored at 4 C
(Hrzenjak et al., 1998).
Experimental animals
Purebred healthy male Wistar albino rats weighing 150–180 g
were procured from the Small Animal Breeding Centre, Agri-
cultural University, Mannuthy, Kerala. Animals were acclima-
tized under standard laboratory conditions at 25 ± 2 C and a
normal photoperiod (12 h light:dark cycle). The animals had
ad libitum access to standard rat chow and water. The food
was withdrawn 18–24 h before the experiment. The care and
use of laboratory animals were conducted according to the
guidelines of the Council Directive CPCSEA, India (No:
659/02/a), on Good Laboratory Practice (GLP) for animal
experimentation. All the animal experiments were performed
in the laboratory according to the ethical guidelines suggested
by the Institutional Animal Ethics Committee (IAEC).
Experimental design
The experimental animals were divided into the following four
groups, each containing six Wistar albino rats, which were
analyzed for a total experimental period of 32 days. Group I
served as a control. In Group II, rats were treated with isopro-
terenol (85 mg/kg bwt administered subcutaneously twice at an
interval of 24 h) dissolved in normal saline. In Group III, rats
were orally pretreated with EWP (200 mg/kg bwt) dissolved in
saline for a period of 30 days and then treated with isopro-
terenol (85 mg/kg bwt administered subcutaneously twice at
an interval of 24 h) at the end of the treatment period on the
31st and 32nd days. In Group IV, rats were pretreated with
EWP (200 mg/kg bwt) dissolved in saline for a period of
30 days. After the experimental regimen, the rats were sacri-
ficed by cervical decapitation under mild chloroform anesthe-
sia. Blood was collected into clean centrifuge tubes by
carotid bleeding and allowed to clot. The serum was then sep-
arated by centrifugation at 3000 rpm for 15 min and stored at
4 C for various biochemical and hematological assays.
Hematological and biochemical assays
Hemoglobin (Hb) (Drabkin and Austin, 1932), red blood cells
(RBC), white blood cells (WBC) (Chesbrough and McArthur,
1972), platelets (Auto analyzer model Cell-Dyn-1700, No.
41884V96, CD-1700-CS, GMI Incorporation, Ramsey, MN,
USA), protein, albumin, globulin, and uric acid were evaluated
using standard protocols described by Lowry et al. (1951),
Wolfson (1948), Caraway (1963).
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Ten milliliters of a chloroform–methanol (2:1 v/v) mixture was
added into a known volume of serum and mixed well for
30 min. The mixture was filtered through Whatman filter paper
(No. 42) into a separating funnel. The filtrate was mixed with
0.2 ml of physiological saline, and the mixture was kept over-
night in undisturbed conditions. The lower phase containing
the lipids was drained off into pre-weighed beakers, and the
upper phase was re-extracted with additional chloroform–
methanol mixture. The extracts were pooled and evaporated
under vacuum at room temperature. The lipid extract was
re-dissolved in 3 ml of a chloroform–methanol (2:1) mixture,
and aliquots were removed to estimate the serum lipid concen-
trations. Total cholesterol (Parekh and Jung, 1970), triglyc-
erides (Rice, 1970), free fatty acids (Horn and Menahan,
1981), phospholipids (Rouser et al., 1970) and HDL
(Warnick et al., 1985) were assayed in each serum sample,
and the lipids were extracted via the method reported by
Folch and Lees (1957).
Separation of LDH isoenzymes in serum by electrophoresis
LDH isoenzymes were analyzed based on the in vivo toxicity
mediated by ISO with the method of gel electrophoresis where
1% agarose gels were prepared and the experimental and con-
trol serum samples were loaded into successive wells. After
electrophoresis, the gel was removed and stained by the follow-
ing method: the gel was incubated with staining solution at
37 C in the dark for a suitable period; the staining solution
contained 1.0 ml of 1.0 M lithium lactate, 1.0 ml of 0.1 M
sodium chloride, 1.0 ml of 5.0 mM magnesium chloride,
2.5 ml of 0.1% (w/v) nitro blue tetrazolium (NBT), 0.25 ml
of 0.1% phenazine methosulfate, 2.5 ml of 0.5 M phosphate
buffer, pH 7.5, and 10 mg of NAD in a total volume of
10 ml. The separated LDH isoenzymes appeared as purple
bands. Finally, the gel was washed with 7.5% acetic acid, pre-
served in 5% acetic acid, and scanned using a densitometer
(Mckenzie and Henderson, 1983).
Data analysis
The results are expressed as the mean ± SEM. One-way
ANOVA was performed, and the statistical comparisons
among the groups were performed with Turkey’s test using sta-
tistical analysis software (SPSS 10.0 for Windows). DifferencesTable 1 ISO-mediated changes in the levels of the hematological par
earthworm powder (E. eugeniae).
Groups Hb (g%) Platelets (k/
Group I 13.57 ± 0.32 3.51 ± 0.23
Group II 17.48 ± 0.26a,* 5.61 ± 0.27a
Group III 14.56 ± 0.23b 3.46 ± 0.35b
Group IV 14.45 ± 0.34c 3.49 ± 0.31c
Values are expressed as the mean ± SD of the six animals in each group. C
Groups:Group I: Control; Group II: ISO (85 mg/kg bwt); Group III: ISO
(200 mg/kg bwt).
* Statistically significant at p < 0.05.among the means were analyzed by Duncan’s multiple range
test (DMRT) at the 5% level (p< 0.05).
Result
Valuation of hematological and biochemical parameters
Table 1 shows the results of a hematological assay of the blood
from the control and ISO-mediated rats that were treated or
not with EWP from E. eugeniae. RBC levels were decreased
in rats in Group II compared to control (Group I) rats. A
simultaneous increase in hemoglobin content and hematocrit
value was noticed in Group I animals, the condition was nor-
malized by the treatment of EWP of E. eugeniae at 200 mg/
kg bwt. Furthermore, as shown in Fig. 1, the biochemical
parameters in ISO-mediated rats showed that the level of total
protein and the A/G ratio in the serum decreased significantly
and the glucose and uric acid contents in the serum increased
compared with the control rats (p< 0.05).
Lipid profile assessment
Table 2 depicts the lipid profiles of the sera of the control and
ISO-treated rats that were treated or not with EWP from E.
eugeniae. The ISO-treated rats showed significantly increased
levels of TC, FFA, TG, PL LDL and VLDL, which were asso-
ciated with a significant decrease in HDL levels compared to
the control rats (p> 0.05). The ISO-treated rats in Group
III that were orally pretreated with EWP (200 mg/kg bwt)
showed a significant (p< 0.05) decrease in the levels of TC,
FFA, TG, PL, LDL, and VLDL that was associated with a
significant increase in HDL compared to ISO-treated rats with
cardio toxicity; these levels, except for the HDL and LDL
levels, were close to those in the control rats.
LDH isoenzyme expression
ISO (85 mg/kg bwt) treatment caused increased expression of
LDH isoenzymes, predominantly LDH1, compared to the
control rats (Fig. 2). The elevation of these LDH isoenzymes
was normalized with the EWP treated Group III animals.
Discussion
Blood is a good indicator of the health of an organism. It also
acts as a pathological indicator of the whole body and henceameters in control and experimental rats and their attenuation by
ll) WBC (106/ll) RBC (109/ll)
2.55 ± 0.26 7.56 ± 0.21
,* 3.75 ± 0.16a,* 6.40 ± 0.24a,*
2.55 ± 0.27b 7.41 ± 0.25b
2.70 ± 0.18c 7.46 ± 0.32c
omparisons with aGroup II and bGroup III. cGroup IV and Group I.
(85 mg/kg bwt) + EWP (200 mg/kg bwt); and Group IV: EWP alone
Figure 2 Electrophoretic pattern of elevated LDH isoenzyme
levels by the free radical damage induced by ISO, normalization of
isoenzymes by EWP treated at 200 mg/kg bwt and control rats.
L1, Group I rats (control); L2, Group II rats treated with ISO; L3,
Group III rats orally pretreated with 200 mg/kg bwt of EWP and
treated with ISO; L4, Group IV rats treated with 200 mg/kg bwt of
EWP.
Figure 1 Evaluation of serum protein, A/G ratio, glucose and
uric acid levels in ISO-treated and control rats. Group I: control;
Group II: ISO (85 mg/kg bwt); Group III: ISO (85 mg/kg bwt)
+ EWP (200 mg/kg bwt); and Group IV: EWP alone (200 mg/
kg bwt). Each column represents the mean ± SD of the six
animals in each group. *Statistically significant at p < 0.05.
4 J. Anitha et al.hematological parameters are important for diagnosing the
functional status of an animal exposed to toxicant (Joshi
et al., 2002). Anemia treatment may be an important part of
MI taking this in account, the results of hematological assay
of the blood from the control and ISO-mediated rats showed
decreased levels of RBC in Group II rats compared to control
rats, in accordance with the previous report by Cemin et al.
(2011). A significant increase in the hemoglobin content and
hematocrit value was found in ISO-mediated rats following
treatment with the EWP of E. eugeniae compared with the con-
trol, which is in accordance with the study by Tarasov (1976),
who showed a significant increase in total blood parameters in
acute myocardial infarction (AMI) patients compared to nor-
mal subjects.
A decrease in serum proteins is usually due to the decrease
in albumin or sometimes gamma globulin that occurs due to
infections, burns, stress, or heart attacks (Gowenlock et al.,
2002). The ISO-induced myocardial infarctions in the rats in
Group II may have generated free radical mediated damage
that may lead to the production of more oxygen and hydrogen
peroxide ions, which in turn could bind to albumin andTable 2 ISO-mediated changes in the levels of cholesterol, triglyceri
serum of the Wistar rat model and their attenuation by earthworm
Parameters (mg/dl) Control ISO
TC 89.63 ± 0.02 125.35 ±
FFA 42.15 ± 0.03 73.23 ±
TG 25.83 ± 18.06 66.3 ±
PL 99.25 ± 0.01 116.28 ±
HDL 46.03 ± 0.62 31.29 ±
LDL 54.16 ± 1.03 96.16 ±
VLDL 11.15 ± 1.22 15.25 ±
Values are expressed as the mean ± SD of the six animals in each group. C
Groups:Group I: Control; Group II: ISO (85 mg/kg bwt); Group III: ISO
(200 mg/kg bwt).
* Statistically significant at p < 0.05.destroy serum proteins (Nivethetha et al., 2009). ISO-
induced free radical generation, which tends to reduce the pro-
tein levels and A/G ratio and increase glucose levels in rat
serum, was reversed by treatment with EWP at 200 mg/kg bwt.
Therefore, MI might be due to an increased release of free rad-
icals from the damaged myocardium into the systemic circula-
tion. This is in agreement with the findings of Upaganlawar
and Balaraman (2012), who suggested that lycopene increases
protein levels and the A/G ratio and decreases glucose levels in
ISO-treated rats.
Tissue is disturbed under hypoxic conditions, and the
enzyme xanthine dehydrogenase is converted into xanthine
oxidase by the oxidation of the essential SH group. Xanthine
oxidase catalyzes the conversion of hypoxanthine to xanthine,
uric acid, and superoxide (Rajadurai and Prince, 2007). This
might be the reason for the elevation in the uric acid level in
the present study. Rats treated with EWP (200 mg/kg bwt)
(Group III) can undergo xanthine metabolism to alleviate
the toxicity induced by isoproterenol; this relief from toxicity
is similar to the normalization of serum uric acid levels indes, free fatty acids, phospholipids, HDL, LDL and VLDL in the
powder (E. eugeniae).
EWP+ ISO EWP alone
1.4a 86.33 ± 0.20b 89.61 ± 0.02c
0.16a,* 41.3 ± 0.01b 42.05 ± 0.03c
0.02a,* 24.31 ± 0.02b 25.43 ± 18.06c
0.02a,* 98.36 ± 0.04b 99.25 ± 0.01c
0.99a,* 58.96 ± 1.48b 46.03 ± 0.62c
1.15a,* 60.10 ± 1.39b 54.16 ± 1.03c
0.22a,* 10.95 ± 1.75b 11.15 ± 1.22c
omparisons with aGroup II and bGroup III. cGroup IV and Group I.
(85 mg/kg bwt) + EWP (200 mg/kg bwt); and Group IV: EWP alone
Eudrilus eugeniae attenuates b-adrenoceptor toxicity mediated by isoproterenol 5ISO-treated rats after pretreatment with naringin (Abirami
and Kanagavalli, 2013).
High levels of circulating cholesterol and its accumulation
in heart tissue are strongly associated with cardiovascular
damage (Deepa and Varalakshmi, 2005). In the present inves-
tigation, ISO-treated rats (Group II) showed an increase in the
levels of TC, FFA, TG, PL, LDL, and VLDL that was associ-
ated with a significant decrease in serum HDL compared to
control rats. ISO administration has been reported to stimulate
adenylate cyclase activity, resulting in enhanced cAMP forma-
tion, which increases lipid biosynthesis and leads to hyperlipi-
demia via phospholipase A2 in circulation (Franson et al.,
1972).
The higher levels of serum free fatty acids in animals treated
with ISO are reported to result from the increased levels of
lipolysis (Patil et al., 2007). LDL carries most of the cholesterol
in the plasma, and increases in LDL levels depend on increas-
ing levels of total cholesterol. Several studies have indicated
that the ratios of LDL-cholesterol/HDL-cholesterol and total
cholesterol/HDL-cholesterol can be good indexes of
atherosclerotic injury in the walls of vessels (Ithayarasi and
Devi, 1997). The high levels of VLDL in ISO-treated animals
could be due to the decreased activity of extra hepatic lipopro-
tein lipase (Prabhu et al., 2006). The contents of TC, FFA, TG,
PL, LDL, VLDL, and HDL were brought to near-normal
levels in EWP-treated rats (200 mg/kg bwt) potentially due to
the membrane-stabilizing activity of EWP. This effect may
increase the capacity of myocytes to regenerate new phospho-
lipids, which are necessary to repair damaged membranes.
The measurement of serum LDH isoenzymes by agarose gel
electrophoresis is necessary for greater specificity in assessing
cardiac injury because a non-specific increase in total LDH
isoenzymes in serum causes tissue damage. Due to the necrosis
induced by ISO, the heart-specific isoenzyme LDH1 could be
released into the blood circulation. In the present study, an
increase in the LD1, LD2, LD3, LD4, and LD5 isoenzyme
bands in rats with an ISO-mediated myocardial infarction
was observed, which is supported by the previous findings of
Prabhu et al. (2006), who stated that mangiferin exerts a ben-
eficial effect on the LDH pattern in rats with an ISO-induced
MI. EWP is rich in phenol, which possesses antioxidant activ-
ity (Anitha and Jayraaj, 2012), and this could contribute to its
mechanism of action to protect the myocardium from damage
and to prevent the leakage of lipids and LDH isoenzymes into
the blood. These results are supported by the results of the rats
in Group IV, who were pretreated with 200 mg/kg bwt of EWP
alone.
Conclusion
Finally the EWP treatment of ISO-mediated rats (200 mg/
kg bwt) had a tendency to ameliorate the changes mediated
by ISO without any adverse side effects and hence, these
results help us to understand the pharmacological potential
of EWP in normalizing the parameters analyzed in rat model.
The isolation of the pure compound responsible for these sta-
bilizing properties is now in progress.
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